The Medicines Agency of France (ANSM) issued an alert regarding a contraceptive containing desogestrel, warning approximately 1.6 million women who use this contraceptive method about a possible tumor risk.
ANSM recommends that women taking this medication consult a doctor if they present symptoms such as persistent headaches, visual disturbances or memory loss.
The alert follows concerns raised by the European Medicines Agency (EMA) regarding the safety of this type of contraceptive and its potential link to tumor development.
French health authorities are monitoring the situation and informing women about the warning signs that should prompt immediate medical consultation.
